International Congress on the Future of Breast Cancer
Prognostic Link Between pCR and Survival Outcomes May Be Key to Personalized Medicine Efforts in Early-Stage TNBC
August 21, 2022
Article
At the international congress on the Future of Breast Cancer West, Hope S. Rugo highlighted the predictive value of residual cancer burden scoring in ongoing research efforts to tailor triple-negative breast cancer treatments.
Oral SERDS Open New Door in ESR1-Mutant, ER-Positive Breast Cancer
August 20, 2022
Article
Aditya Bardia, MD, MPH, discusses ongoing research with oral SERDs, such as elacestrant, and highlights what these agents could represent for patients with estrogen receptor–positive breast cancer.
Advertisement
Advertisement